Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
Published August 26, 2026 · Recall initiated: August 7, 2026
Summary
FDA records drug Class II recall D-0771-2026, published August 26, 2026 and initiated August 7, 2026. Recalling firm: Golden State Medical Supply Inc.; Status: Ongoing; Reported quantity: 1200 bottles; Lot: Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP deviations: tablets with black specks.
What to do
Voluntary: Firm initiated · Letter
Get an email if CARBAMAZEPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CARBAMAZEPINE
- Manufacturer
- Golden State Medical Supply Inc.
- Distributor
- USA Nationwide
- Lot
- Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro PharmaceuticalAugust 26, 2026
- FDAAcamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan PharmaceuticalsAugust 26, 2026
- FDALibtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous Infusion After Dilution,August 26, 2026
- FDACarbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only,October 8, 2025
- FDACarbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufactured by: TorrentJanuary 19, 2022
- FDACarbamazepine 200mg Tablets, USP, 200 mg, 100 Count Unit Dose Cartons, Rx only, Manufactured by: TorrentSeptember 29, 2021
Questions about this recall
Was Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA recalled?
Yes. FDA published recall D-0771-2026 on August 26, 2026. Reported hazard: CGMP deviations: tablets with black specks.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CARBAMAZEPINE.